GNRH1 and endometriosis: Patients with stage III and IV endometriosis, as determined by the rASRM (American Society of Reproductive Medicine), were treated for six months with medications from the gonadotropin-releasing hormone (GnRH) agonist group, followed by “second-look” laparoscopy to reassess the cytokines in peritoneal fluid.